家畜用ワクチンの世界市場規模：ワクチンタイプ別：対象動物種別、投与方法別、エンドユーザー別、地域別範囲と予測

家畜用ワクチンの市場規模と予測

家畜用ワクチンの市場規模は、2024年には95億米ドルと評価され、2026～2032年にかけてCAGR 7.25%で成長し、2032年には166億3,000万米ドルに達すると予測されています。

家畜用ワクチンの世界市場促進要因

家畜用ワクチンの市場促進要因は、様々な要因の影響を受ける可能性があります。これらには以下が含まれます。

動物性タンパク質へのニーズの高まり：世界人口の増加に伴い、肉や乳製品の需要が増加しています。このため、健康な家畜に対する要求が高まり、家畜の生産性を低下させる可能性のある病気を食い止めるための予防接種の必要性が高まっています。

家畜の病気の蔓延：畜産業は、口蹄疫、鳥インフルエンザ、豚繁殖・呼吸器症候群（PRRS）などの病気により、大きな経済的損失を被る可能性があります。これらの疾病の予防と制御に予防接種が重要な役割を果たすことから、家畜用ワクチンの必要性が高まっています。

政府の取り組みと法律：動物疾病の蔓延を食い止めるため、政府や規制機関は頻繁にプログラムや法律を制定しています。これには予防接種キャンペーンも含まれ、家畜用ワクチンの一貫した必要性を生み出しています。

技術開発：バイオテクノロジーとワクチン研究の開発により、より優れた、より安全なワクチン接種が可能になりました。このような開発は市場の創造性を刺激し、市場の拡大に貢献しています。

動物衛生への投資の増加：動物用ワクチン市場は、動物ヘルスケアを支えるインフラへの投資の増加や、動物の健康と福祉の重要性に対する意識の高まりにより拡大しています。

貿易のグローバリゼーション：貿易が拡大するにつれ、疾病が国際的に蔓延する可能性が高まっています。その結果、新しい地域への病気の導入と蔓延を食い止めるために、予防接種キャンペーンがより重要になっています。

人獣共通感染症は、動物から人へ感染する可能性のある感染症で、より一般的になりつつあります。動物用ワクチンの必要性は、特定の病気に対して動物に予防接種をすることで、動物を守るだけでなく、人に感染する可能性を低くすることができるという事実が後押ししています。

予防ヘルスケアへの移行：畜産業の傾向として、農業従事者は病気の治療よりも予防に重点を置くようになってきています。これにより、ワクチン接種プログラムの普及が促進され、農業動物向けワクチンの市場が拡大します。

集中農法の採用拡大：家畜は密接に飼育されるため、濃厚飼料施設（CAFO）のような集約的農法は疾病発生の危険性を高めています。このような環境では病気の蔓延を食い止めるためにワクチン接種が重要であるため、家畜用ワクチンのニーズが高まっています。

世界の家畜用ワクチン市場抑制要因

家畜用ワクチンの市場には、いくつかの要因が抑制要因や課題として作用する可能性があります。これらには以下が含まれます。

規制の難しさ：規制の難しさ：ワクチンの認可手続きには時間がかかり、厳格であるため、市場の導入や成長に遅れが生じる可能性があります。

高額な開発費：家畜用ワクチンの開発に伴う研究開発費は、市場参入企業を制限し、ワクチン価格を押し上げる可能性があります。

限られた知識：一部の地域では、家畜に対するワクチン接種の利点を知らない農業従事者や、その有効性に疑念を持つ農業従事者によって、市場の成長が妨げられる可能性があります。

インフラの課題：ワクチンの流通、投与、保管のためのインフラが不十分であるため、特に新興国では開発が阻害される可能性があります。

サブセグメンテーションされた市場：小規模生産者が多いため、家畜用ワクチン市場がセグメント化し、価格上昇の圧力となり、技術革新が制限される可能性があります。

疾病管理技術：特定の農業経営においては、抗生物質の使用やバイオセキュリティ対策などの効果的な疾病管理技術により、ワクチン接種の必要性が明らかに減少する可能性があります。

伝統的医薬品との競合：市場によっては、ワクチンは抗生物質や漢方薬など、伝統的疾病予防・治療手段との競合に直面する可能性があります。

経済的要因：経済的要因：農業従事者がワクチンやその他の予防対策に支出する能力は、経済の低迷や商品価格の変動により影響を受ける可能性があります。

過剰使用に関する懸念：ワクチンの過剰使用により、予防接種に耐性を持つ疾病株が出現したり、家畜の健康に悪影響を及ぼすことが懸念されます。

変化への抵抗：農業従事者や農業コミュニティの中には、ワクチン接種のような新しい技術やプラクティスを導入することに抵抗感を持つ場合があり、市場の拡大を妨げる可能性があります。

目次

第1章 世界の家畜用ワクチン市場の導入

• 市場概要
• 調査範囲
• 前提条件

第2章 エグゼクティブサマリー

第3章 VERIFIED MARKET RESEARCHの調査手法

• データマイニング
• バリデーション
• 一次資料
• データソース一覧

第4章 世界の家畜用ワクチン市場展望

• 概要
• 市場力学
  • 促進要因
  • 抑制要因
  • 機会
• ポーターのファイブフォースモデル
• バリューチェーン分析

第5章 家畜用ワクチンの世界市場：ワクチンタイプ別

• 生ワクチン
• 不活化ワクチン
• サブユニットワクチン
• DNAワクチン

第6章 家畜用ワクチンの世界市場：対象動物種別

• 牛
• 豚
• 家禽
• 羊と山羊

第7章 世界の家畜用ワクチン市場：投与方法別

• 注射用ワクチン
• 経口用ワクチン
• 経鼻用ワクチン

第8章 家畜用ワクチンの世界市場：エンドユーザー別

• 動物病院とクリニック
• 家畜生産者
• 獣医診断ラボ
• 動物保健会社

第9章 家畜用ワクチンの世界市場：地域別

• 概要
• 北米
  • 米国
• カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • フランス
  • その他の欧州
• アジア太平洋
  • 中国
  • 日本
  • インド
  • その他のアジア太平洋
• その他
  • ラテンアメリカ
  • 中東・アフリカ

第10章 世界の家畜用ワクチン市場の競合情勢

• 概要
• 各社の市場ランキング
• 主要開発戦略

第11章 企業プロファイル

• Boehringer Ingelheim
• Merck
• Zoetis
• WINSUN
• Ringpu Biology
• Ceva
• CAHIC
• HVRI
• Bio-Labs
• Yebio

第12章 付録

• 関連調査

Farm Animal Vaccine Market Size And Forecast

Farm Animal Vaccine Market size was valued at USD 9.5 USD Billion in 2024 and is projected to reach USD 16.63 USD Billion by 2032, growing at a CAGR of 7.25% during the forecast period 2026-2032.

Global Farm Animal Vaccine Market Drivers

The market drivers for the Farm Animal Vaccine Market can be influenced by various factors. These may include:

Growing Need for Animal Protein: The demand for meat and dairy products rises in tandem with the growth of the world's population. Because of this, there is a greater requirement for healthy farm animals, which raises the need for vaccinations to stave off illnesses that could lower livestock productivity.

Animal illness prevalence: The cattle business can suffer large financial losses as a result of diseases including foot-and-mouth disease, avian influenza, and porcine reproductive and respiratory syndrome (PRRS). The need for vaccines for agricultural animals is fueled by the critical role immunizations play in both preventing and controlling these diseases.

Government Initiatives and laws: To stop the spread of animal diseases, governments and regulatory agencies frequently put programs and laws into place. This includes immunization campaigns, which generate a consistent need for vaccines for farm animals.

Technological developments: Better and safer vaccinations for farm animals have been made possible by developments in biotechnology and vaccine research. These developments stimulate the market's creativity and aid in its expansion.

Increasing Investments in Animal Health: The market for farm animal vaccines is expanding as a result of rising investments in the infrastructure supporting animal healthcare as well as growing awareness of the significance of animal health and welfare.

Trade Globalization: As trade grows, there is a greater chance that diseases will spread internationally. As a result, immunization campaigns are more important to stop the introduction and spread of illnesses to new areas.

Zoonotic diseases are infections that can spread from animals to people and are becoming more common. The need for farm animal vaccines is fueled by the fact that immunizing animals against certain illnesses not only protects them but also lowers the possibility of human infection.

Transition to Preventive Healthcare: Farmers are putting more of an emphasis on preventing illnesses than treating them as a result of a growing tendency in animal husbandry. This promotes vaccination programs' uptake and expands the market for vaccines intended for agricultural animals.

Growing Adoption of Intensive Farming Practices: Because animals are kept in close quarters, intensive farming methods-like concentrated animal feeding operations (CAFOs)-increase the danger of disease outbreaks. Because vaccinations are crucial in stopping the spread of disease in these kinds of settings, there is an increased need for farm animal vaccines.

Global Farm Animal Vaccine Market Restraints

Several factors can act as restraints or challenges for the Farm Animal Vaccine Market. These may include:

Regulatory Difficulties: The lengthy and rigorous regulatory licensing procedures for vaccines might cause delays in the introduction or growth of the market.

High Development expenditures: Research and development expenditures associated with developing vaccines for farm animals might restrict market participants and drive up vaccine pricing.

Limited Knowledge: The growth of the market may be hampered in some areas by farmers who are unaware of the advantages of vaccinations for their animals or who have doubts about their effectiveness.

Infrastructure Challenges: Inadequate infrastructure for the distribution, administration, and storage of vaccines might obstruct market expansion in some areas, particularly in developing nations.

Fragmented Market: Due to the large number of small-scale producers, the market for farm animal vaccines may be fragmented, which could put pressure on prices and restrict innovation.

Disease Control techniques: In certain farming operations, the apparent need for vaccinations may be lessened by effective disease control techniques such the use of antibiotics and biosecurity measures.

Competition from Traditional Medicines: In certain markets, vaccines may face competition from traditional means of illness prevention and treatment, such as antibiotics or herbal medicines.

Economic Factors: Farmers' capacity to spend in vaccines and other preventive measures may be impacted by downturns in the economy or changes in commodity prices.

Concerns regarding Overuse: There may be worries that using vaccines excessively could result in the emergence of disease strains resistant to vaccinations or have a negative impact on the health of animals.

Resistance to Change: Some farmers or farming communities may be resistant to implementing new technologies or practices, such as vaccinations, which could impede the expansion of the market.

Global Farm Animal Vaccine Market Segmentation Analysis

The Global Farm Animal Vaccine Market is Segmented on the basis of Type of Vaccine, Target Animal Species, Administration Method, End-User, and Geography.

Farm Animal Vaccine Market, By Type of Vaccine

• Live Attenuated Vaccines: Vaccines containing weakened forms of the pathogen that stimulate an immune response in animals without causing disease, providing long-lasting immunity with a single dose.
• Inactivated Vaccines: Vaccines containing killed or inactivated pathogens, which require multiple doses or booster shots to induce immunity but are safer for use in pregnant animals and young animals with developing immune systems.
• Subunit Vaccines: Vaccines composed of specific antigens or proteins from the pathogen, offering targeted immune responses with reduced risk of adverse reactions compared to whole-cell vaccines.
• DNA Vaccines: Vaccines that deliver genetic material encoding antigenic proteins into animal cells, stimulating both humoral and cellular immune responses for long-term protection against pathogens.

Farm Animal Vaccine Market, By Target Animal Species

• Cattle: Vaccines developed specifically for cattle to prevent diseases such as bovine respiratory disease (BRD), bovine viral diarrhea (BVD), infectious bovine rhinotracheitis (IBR), and clostridial infections.
• Pigs: Vaccines designed for pigs to protect against diseases such as porcine reproductive and respiratory syndrome (PRRS), swine influenza, porcine circovirus-associated diseases (PCVAD), and classical swine fever.
• Poultry: Vaccines formulated for poultry species including chickens, turkeys, and ducks to prevent diseases such as Newcastle disease, infectious bronchitis, avian influenza, Marek's disease, and infectious bursal disease.
• Sheep and Goats: Vaccines tailored for sheep and goats to control diseases such as foot-and-mouth disease (FMD), enterotoxemia, clostridial infections, and contagious ecthyma (orf).

Farm Animal Vaccine Market, By Administration Method

• Injectable Vaccines: Vaccines administered through injection into muscle tissue or under the skin, providing targeted delivery and reliable immune responses.
• Oral Vaccines: Vaccines administered orally through feed or drinking water, offering ease of administration and potential for mass vaccination of large animal populations.
• Intranasal Vaccines: Vaccines delivered through the nasal passages, stimulating mucosal immunity and providing protection against respiratory pathogens in farm animals.

Farm Animal Vaccine Market, By End-User

• Veterinary Hospitals and Clinics: Facilities providing veterinary services and healthcare to farm animals, including vaccination programs, preventive care, and treatment of infectious diseases.
• Livestock Producers: Farmers, ranchers, and livestock producers responsible for managing the health and well-being of farm animals, including implementing vaccination protocols and disease prevention strategies.
• Veterinary Diagnostic Laboratories: Laboratories conducting diagnostic tests, serological assays, and vaccine efficacy studies to monitor disease prevalence, assess vaccine effectiveness, and guide vaccination strategies.
• Animal Health Companies: Manufacturers and suppliers of farm animal vaccines, veterinary pharmaceuticals, and biological products, offering a range of vaccine formulations and solutions for disease prevention and control.

Farm Animal Vaccine Market, By Geographic

• North America: Market dynamics and trends specific to the farm animal vaccine industry in North American regions, including the United States, Canada, and Mexico.
• Europe: Market factors and regulatory influences shaping the farm animal vaccine market across European countries such as the UK, Germany, France, and Italy.
• Asia Pacific: Growth opportunities and market expansion strategies relevant to farm animal vaccines in countries like China, India, Japan, and Australia.
• Latin America: Market trends and consumer preferences impacting the farm animal vaccine market in Latin American regions like Brazil, Argentina, and Chile.
• Middle East and Africa: Factors driving demand for farm animal vaccines in regions like the Middle East and Africa, including increasing livestock production, disease outbreaks, and government initiatives for animal health.

Key Players

• The major players in the Farm Animal Vaccine Market are:
• Elanco
• Virbac
• Vetoquinol S.A.

4Hester Biosciences Limited

• Phibro Animal Health Corporation
• HIPRA

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL FARM ANIMAL VACCINE MARKET

• 1.1 Overview of the Market
• 1.2 Scope of Report
• 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

• 3.1 Data Mining
• 3.2 Validation
• 3.3 Primary Interviews
• 3.4 List of Data Sources

4 GLOBAL FARM ANIMAL VACCINE MARKET OUTLOOK

• 4.1 Overview
• 4.2 Market Dynamics
  • 4.2.1 Drivers
  • 4.2.2 Restraints
  • 4.2.3 Opportunities
• 4.3 Porters Five Force Model
• 4.4 Value Chain Analysis

5 GLOBAL FARM ANIMAL VACCINE MARKET, BY TYPE OF VACCINE

• 5.1 Live Attenuated Vaccines
• 5.2 Inactivated Vaccines
• 5.3 Subunit Vaccines
• 5.4 DNA Vaccines

6 GLOBAL FARM ANIMAL VACCINE MARKET, BY TARGET ANIMAL SPECIES

• 6.1 Cattle
• 6.2 Pigs
• 6.3 Poultry
• 6.4 Sheep and Goats

7 GLOBAL FARM ANIMAL VACCINE MARKET, BY ADMINISTRATION METHOD

• 7.1 Injectable Vaccines
• 7.2 Oral Vaccines
• 7.3 Intranasal Vaccines

8 GLOBAL FARM ANIMAL VACCINE MARKET, BY END-USER

• 8.1 Veterinary Hospitals and Clinics
• 8.2 Livestock Producers
• 8.3 Veterinary Diagnostic Laboratories
• 8.4 Animal Health Companies

9 GLOBAL FARM ANIMAL VACCINE MARKET, BY GEOGRAPHY

• 9.1 Overview
• 9.2 North America
  • 9.2.1 U.S.
• 92.2 Canada
  • 9.2.3 Mexico
• 9.3 Europe
  • 9.3.1 Germany
  • 9.3.2 U.K.
  • 9.3.3 France
  • 9.3.4 Rest of Europe
• 9.4 Asia Pacific
  • 9.4.1 China
  • 9.4.2 Japan
  • 9.4.3 India
  • 9.4.4 Rest of Asia Pacific
• 9.5 Rest of the World
  • 9.5.1 Latin America
  • 9.5.2 Middle East And Africa

10 GLOBAL FARM ANIMAL VACCINE MARKET COMPETITIVE LANDSCAPE

• 10.1 Overview
• 10.2 Company Market Ranking
• 10.3 Key Development Strategies

11 COMPANY PROFILES

• 11.1 Boehringer Ingelheim
  • 11.1.1 Overview
  • 11.1.2 Financial Performance
  • 11.1.3 Product Outlook
  • 11.1.4 Key Developments
• 11.2 Merck
  • 11.2.1 Overview
  • 11.2.2 Financial Performance
  • 11.2.3 Product Outlook
  • 11.2.4 Key Developments
• 11.3 Zoetis
  • 11.3.1 Overview
  • 11.3.2 Financial Performance
  • 11.3.3 Product Outlook
  • 11.3.4 Key Developments
• 11.4 WINSUN
  • 11.4.1 Overview
  • 11.4.2 Financial Performance
  • 11.4.3 Product Outlook
  • 11.4.4 Key Developments
• 11.5 Ringpu Biology
  • 11.5.1 Overview
  • 11.5.2 Financial Performance
  • 11.5.3 Product Outlook
  • 11.5.4 Key Developments
• 11.6 Ceva
  • 11.6.1 Overview
  • 11.6.2 Financial Performance
  • 11.6.3 Product Outlook
  • 11.6.4 Key Developments
• 11.11 CAHIC
  • 11.11.1 Overview
  • 11.11.2 Financial Performance
  • 11.11.3 Product Outlook
  • 11.11.4 Key Developments
• 11.8 HVRI
  • 11.8.1 Overview
  • 11.8.2 Financial Performance
  • 11.8.3 Product Outlook
  • 11.8.4 Key Developments
• 11.11 Bio-Labs
  • 11.11.1 Overview
  • 11.11.2 Financial Performance
  • 11.11.3 Product Outlook
  • 11.11.4 Key Developments
• 11.10 Yebio
  • 11.10.1 Overview
  • 11.10.2 Financial Performance
  • 11.10.3 Product Outlook
  • 11.10.4 Key Developments

12 Appendix

• 10.1 Related Research